N-Methylflindersine exhibits significant biological activity, making it relevant in pharmaceutical and biomedical research. It has demonstrated antiproliferative effects against various cancer cell lines, suggesting potential as a lead compound in anticancer drug development. Studies indicate it may interfere with cell cycle progression and induce apoptosis in tumor cells. Additionally, it shows antimicrobial properties, inhibiting the growth of certain pathogenic bacteria and fungi. Its structural features also make it a candidate for investigating structure-activity relationships in natural product derivatives. Research continues to explore its efficacy, mechanism of action, and possible optimization for therapeutic use.